| Product Code: ETC9407356 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Malaria Vaccine Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Malaria Vaccine Market - Industry Life Cycle |
3.4 South Korea Malaria Vaccine Market - Porter's Five Forces |
3.5 South Korea Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Korea Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 South Korea Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 South Korea Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Korea Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of malaria in South Korea |
4.2.2 Government initiatives to eradicate malaria |
4.2.3 Rising awareness about the importance of vaccination |
4.3 Market Restraints |
4.3.1 Limited access to healthcare facilities in rural areas |
4.3.2 High cost associated with malaria vaccines |
4.3.3 Potential side effects of malaria vaccines |
5 South Korea Malaria Vaccine Market Trends |
6 South Korea Malaria Vaccine Market, By Types |
6.1 South Korea Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 South Korea Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 South Korea Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 South Korea Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 South Korea Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 South Korea Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 South Korea Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 South Korea Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 South Korea Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 South Korea Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 South Korea Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 South Korea Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 South Korea Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 South Korea Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 South Korea Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 South Korea Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 South Korea Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 South Korea Malaria Vaccine Market Import-Export Trade Statistics |
7.1 South Korea Malaria Vaccine Market Export to Major Countries |
7.2 South Korea Malaria Vaccine Market Imports from Major Countries |
8 South Korea Malaria Vaccine Market Key Performance Indicators |
8.1 Number of malaria cases reported annually |
8.2 Percentage of population vaccinated against malaria |
8.3 Funding allocated by the government for malaria vaccination programs |
9 South Korea Malaria Vaccine Market - Opportunity Assessment |
9.1 South Korea Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Korea Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 South Korea Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 South Korea Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Korea Malaria Vaccine Market - Competitive Landscape |
10.1 South Korea Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 South Korea Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here